| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.8 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |